VR Logo

Eris Lifesciences Ltd


Healthcare | Drugs & Pharma

we think vacations are for wimps

49 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

Financial Year Full AR Chairman's
Speech
Director's
Report
Management
Discussion
Corporate
Governance
Auditor's
Report
Notes to
Accounts
2021 download pdf full AR
2020 download pdf full AR download pdf chairman speech download pdf director's report download pdf management discussion download pdf corporate governance download pdf auditor's report download pdf account notes
2019 download pdf full AR download pdf chairman speech download pdf director's report download pdf management discussion download pdf corporate governance download pdf auditor's report download pdf account notes
2018 download pdf full AR download pdf chairman speech download pdf director's report download pdf management discussion download pdf corporate governance download pdf auditor's report download pdf account notes
2017 download pdf full AR download pdf chairman speech download pdf director's report download pdf management discussion download pdf corporate governance download pdf auditor's report download pdf account notes

About The Company

Business: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Incorporated: 2007

Chairman: Amit Indubhushan Bakshi

Managing Director: Amit Indubhushan Bakshi

Group: --

Listing: NSE: ERIS, BSE: 540596

Headquarters: Ahmedabad, Gujarat

Website: www.eris.co.in

Key Facts

Market cap: R 9,760.95 Cr

Revenue (TTM): R 1,297.57 Cr

Earnings (TTM): R 383.45 Cr

Cash: R 88.68 Cr

Total Debt: R 0.01 Cr

Promoters' ownership: 52.68%

Liquidity: High

52 Week range: R 473.50 - 863.15

Face value: R1.00

Shares outstanding: 13,59,08,589

10 Years Aggregate:

  • CFO: 1,683.66 Cr
  • EBITDA: 2,271.60 Cr
  • Net Profit: 1,874.91 Cr

Stock Performance

Time Period Eris Lifesciences S&P BSE Healthcare S&P BSE Small Cap
YTD24.0817.6254.37
1 month-12.351.87-0.16
3 months-1.16-4.023.78
1 Year37.6625.2864.87
3 Years4.9621.1524.62
5 Years--10.1317.76
10 Years--15.4516.43
As on 30-Nov-2021
Year Eris Lifesciences S&P BSE Small Cap S&P BSE Healthcare
202016.8332.1161.45
2019-31.52-6.85-3.55
2018-13.43-23.41-5.89